表紙
市場調査レポート

米国のポイントオブケア(POC)血液検査とフローサイトメトリー市場の分析

2015-2019 US Decentralized/POC Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

発行 Venture Planning Group 商品コード 273303
出版日 ページ情報 英文 238 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
米国のポイントオブケア(POC)血液検査とフローサイトメトリー市場の分析 2015-2019 US Decentralized/POC Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
出版日: ページ情報: 英文 238 Pages
概要

当レポートでは、米国のポイントオブケア(POC)血液検査とフローサイトメトリー市場について調査分析し、主要動向、市場規模、成長率、規制要件、技術動向、競合情勢のほか、検査用装置・消耗品サプライヤーの新興の機会について検証して、概略以下の構成でお届けいたします。

イントロダクション

エグゼクティブサマリー

分散化検査の論理的根拠

  • 概要
  • 規制動向
  • 経済動向
  • 人口統計動向
  • 技術動向
  • 社会動向
  • ケアの質
  • 防衛的医療
  • 品質管理(QC)の問題点

定期的・特殊血液検査

  • CBC(全血球計算)分析

検査用装置:血液分析器

現在/新興の技術

  • モノクローナル抗体
  • イムノアッセイ
  • ドライケミストリー
  • バイオセンサー
  • ITとオートメーション
  • 分子診断

米国

  • 市場概要
  • 診療所/医師団
  • 補助的病院施設
  • がんクリニック
  • 外来診療センター
  • 手術センター
  • 介護施設
  • 産院
  • 主要サプライヤーの検査用装置の設置台数、設置ベース、消耗品の売上高・市場シェア

主な製品開発の機会

分散型検査製品の設計基準

代替的な市場浸透戦略

  • 国内開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略

潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

企業プロファイル

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • 堀場製作所
  • Iris
  • 日本光電
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPDC10966

This new 238-page report from VPGMarketResearch contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Major Routine and Special Hematology Tests

  • 1. CBC Analysis
    • a. Hemoglobin Concentration
    • b. Hematocrit Determination
    • c. Red Blood Cell Count
    • d. Platelets

Instrumentation: Hematology Analyzers Manufactured by:

  • Abbott
  • Becton Dickinson
  • Beckman Coulter/Danaher
  • Biocode
  • Drew-Scientific
  • Diesse Ves Matic
  • Horiba
  • Menarini
  • Nihon Kohden
  • Polymedco
  • Sysmex

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

  • A. Market Overview
    • 1. Business Environment
      • a. Health Care Expenditures
      • b. Cost Consciousness
      • c. Reimbursement
      • d. Industry Consolidation
      • e. Managed Care
        • PPO
        • HMO
      • f. Hospitals
      • g. Admissions
      • h. Length of Stay
      • i. Industry Diversification
      • j. Physician Demographics
      • k. Aging Population
        • More Chronic Illness
        • Disease Incidence
        • Susceptibility to latrogenesis
        • Multiple Illnesses Cases
      • l. Laboratory Regulations
    • 2. Market Structure
      • a. Hospitals
      • b. Commercial/Private Laboratories
  • B. Physician Offices/Group Practices
    • 1. Market Summary
    • 2. Market Structure
    • 3. Test Volume and Sales Forecasts
  • C. Ancillary Hospital Locations
    • 1. Introduction
      • a. Emergency Departments
      • b. Operating Suites
      • c. Intensive Care Units
    • 2. Emergency Departments
      • a. Market Summary
      • b. Test volume and Sales Forecasts
    • 3. Operating and Recovery Suites
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
    • 4. ICUs/CCUs
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
  • D. Cancer Clinics
    • 1. Introduction
    • 2. Market Summary
    • 3. Test Volume and Sales Forecasts
  • E. Ambulatory Care Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • F. Surgery Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • G. Nursing Homes
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • H. Birth Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • I. Major Suppliers' Instrument Placements, Installed Base, Instrument and Consumables Sales, and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • Horiba
  • Iris
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex

List of Tables

  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Routine Hematology Test Volume Forecast
  • U.S.A., Physician Offices Laboratories Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Consumables Market Forecast
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Routine Hematology Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Hematology Reagent Market Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
  • U.S.A., Hospital ICUs/CCUs Routine Hemagology Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
  • U.S.A., Cancer Clinics Routine Hematology/Flow Cytometry Test Volume Forecast
  • U.S.A., Cancer Clinics Hematology and Flow Cytometry Reagent Market Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Routine Hematology Test Volume Forecast
  • U.S.A., Surgery Centers Hematology Consumable Market Forecast
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Routine Hematology Test Volume Forecast
  • U.S.A., Nursing Homes Hematology Reagent Market Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Routine Hematology Test Volume Forecast
  • U.S.A., Birth Centers Hematology Reagent Market Forecast
  • U.S.A., Hematology Analyzers Estimated Placements and Installed Base
  • U.S.A., Flow Cytometers Estimated Placements and Installed Base
  • U.S.A., Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hematology Instrument Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hematology Consumable Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Instruments Market Estimated Market Shares of Major Suppliers
Back to Top